维普中文期刊产品整合服务
19篇 您的检索式:作者名="Judit A"
    题名 作者 年代 出处 被引量
1Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies显示文摘Normal cells are hijacked by cancer cells forming together heterogeneous tumor masses immersed in aberrant communication circuits that facilitate tumor growth and dissemination.Besides the well characterized angiogenic effect of some tumor-derived factors;others,such as BDNF,recruit peripheral nerves and leukocytes.The neurogenic switch,activated by tumor-derived neurotrophins and extracellular vesicles,attracts adjacent peripheral fibers(autonomic/sensorial)and neural progenitor cells.Strikingly,tumor-associated nerve fibers can guide cancer cell dissemination.Moreover,IL-1β,CCL2,PGE2,among other chemotactic factors,attract natural immunosuppressive cells,including T regulatory(Tregs),myeloid-derived suppressor cells(MDSCs),and M2 macrophages,to the tumor microenvironment.These leukocytes further exacerbate the aberrant communication circuit releasing factors with neurogenic effect.Furthermore,cancer cells directly evade immune surveillance and the antitumoral actions of natural killer cells by activating immunosuppressive mechanisms elicited by heterophilic complexes,joining cancer and immune cells,formed by PD-L1/PD1 and CD80/CTLA-4 plasma membrane proteins.Altogether,nervous and immune cells,together with fibroblasts,endothelial,and bone-marrow-derived cells,promote tumor growth and enhance the metastatic properties of cancer cells.Inspired by the demonstrated,but restricted,power of anti-angiogenic and immune cell-based therapies,preclinical studies are focusing on strategies aimed to inhibit tumor-induced neurogenesis.Here we discuss the potential of anti-neurogenesis and,considering the interplay between nervous and immune systems,we also focus on anti-immunosuppression-based therapies.Small molecules,antibodies and immune cells are being considered as therapeutic agents,aimed to prevent cancer cell communication with neurons and leukocytes,targeting chemotactic and neurotransmitter signaling pathways linked to perineural invasion and metastasis.Rodolfo Daniel Cervantes-Villagrana Damaris Albores-García Alberto Rafael Cervantes-Villagrana Sara Judit García-Acevez 2020Signal Transduction and Targeted Therapy2020,5,1:5
2Within-Plant Distribution and Sampling of Single and Mixed Infestations of Bemisia tabaci and Trialeurodes vaporariorum ( Homoptera : Aleyrodidae) in Winter Tomato Crops显示文摘Judit A Ramon A Rosa G 2006Journal of Economic Entomology2006,99,2:1
3ZD1839, a Specific epidermal growth factor receptor(EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/HER3 heterodimers and prevents heregulin Signaling in HER2 - overexpressing breast cancer cells 显示文摘Judit A Pablo M Joan AI 2003Clinical Cancer Research2003,9,:1
4Cellular control of gene expression by T-type cyclin/CDK9 complexes显示文摘 GRAN A X 2004Gene2004,337,:1
5Prevalence and risk factors of human papilloma virus infection in asymptomatic women in southeastern Hungary显示文摘Tibor A N La szlo K Judit D 2004European Journal of Obstetrics & Gynecology and Reproductive Biology2004,115,1:1
6Comprehensive Functional Assessment of MLH1 Variants of Unknown Significance显示文摘Ester Borràs Marta Pineda Angela Brieger Inga Hinrichsen Carolina Gómez Matilde Navarro Judit Balma?a Teresa Ramón y Cajal Asunción Torres Joan Brunet Ignacio Blanco Guido Plotz Conxi Lázaro Gabriel Capellá 2012Human Mutation2012,,1:1
7Coordiation of the cell cycle is an impor- tant determinant of the syndrome of acute renal failure显示文摘Judit M Lucia A Jose M 2002Am J Physiol Renal Physio12002,283,4:1
8Gene expression profiling of intestinal regeneration in the sea cucumber 显示文摘Pablo A Ortiz-Pineda Francisco Ramffez-G6mez Judit P6rez-Ortiz 2009BMC Genomics2009,10,:1
9ZD1839, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/ HER3 heterodimers and prevents heregulin signaling in HER2 -overexpressing breast cancer cells 显示文摘JUDIT A PABLO M JOAN A 2003Clinical Cancer Research2003,,9:1
10Evaluation of mathematical models describing durg release fromlipophilic matrices显示文摘Judit D Istvan A 1996Int J Pharm1996,145,1:1
11显示文摘Judit A Robert T Renita W 2001Pdeiatr Res2001,49,1:1
12Micropropagation of apple:a review显示文摘Judit D Jaime A 2010Biotechnological Advances2010,28,:1
13Evaluation of mathematical models describing durg release from lipophilic matrices 显示文摘Judit D Istvan A 1996Int J Pharm1996,145,1:1
14Toxicidad hepática inducida por los nuevos fármacos inmunosupresores显示文摘Elena Toscano Judit Cotta Mercedes Robles M a Isabel Lucena Raúl J. Andrade 2009Gastroenterologia y Hepatologia2009,,1:1
15Ki?netic of elementary reactions in low-temperature autoig?nition chemistry 显示文摘Judit Zador Craig A Taatjes Ravi X Fernandes 2011Progress in Energy and Combustion Science2011,37,4:1
16Coordiation of the cell cycle is an important determinant of the syndrome of acute renal failure 显示文摘Judit M Lucia A Jose M 2002Am J Physiol Renal Physiol2002,283,4:1
17Biological control of Bemisia tabaci using predators and parasitoids显示文摘Gerling D Oscar A Judit A 0,,9:1
18Evaluation of mathematical models describing drug release from lipophilic matrices显示文摘Judit D Istvan A 1996Int J Pharm1996,145,1:1
19Development of novel Gemini-cholesterol analogues for retinoid-related orphan receptors显示文摘Retinoic-acid-related Orphan Receptors (RORs) regulate the maintenance of the circadian rhythm and immune response among others and are involved in increasing numbers of pathologies including autoimmune diseases, cancer and neurological disorders leading to huge interest in the development of ROR ligands. Here, we describe the synthesis of six novel Gemini cholesterol analogues and the binding mode of one of them to RORγ.Uxía Gómez-Bouzó Alioune Fall Judit Osz Yagamare Fall ORCID logo Natacha Rochel Hugo Santalla 2022Organic Chemistry Frontiers2022,9,6:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费